Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trialJayesh Desai, Andrés Cervantes, Thomas B. Karasic et al.|Nature Medicine|2023Cited by 128
Abstract CT029: Phase Ib study of GDC-6036 in combination with cetuximab in patients with colorectal cancer (CRC) with <i>KRAS G12C</i> mutationJayesh Desai, Manish Patel, Sae‐Won Han et al.|Cancer Research|2023Cited by 10